Mother died from side-effect of cancer drug, inquest told
Ann Healy, aged 66, of Glasnamana Road, Finglas died on December 3, 2018 in the Mater Hospital in Dublin as a result of developing a serious complication of diabetes known as diabetic ketoacidosis from receiving the drug, pembrolizumab, to treat her lung cancer, an inquest heard.
The daughter of a Dublin woman who died as a result of a rare but known side-effect of a powerful new treatment for cancer said her mother might still be alive if she had not been given the drug.
An inquest at Dublin Coroner’s Court heard Ann Healy, aged 66, of Glasnamana Road, Finglas died on December 3, 2018 in the Mater Hospital in Dublin as a result of developing a serious complication of diabetes known as diabetic ketoacidosis from receiving the drug, pembrolizumab, to treat her lung cancer.
